Changes in the gut microbiome and fermentation products concurrent with enhanced longevity in acarbose-treated mice

BACKGROUND: Treatment with the α-glucosidase inhibitor acarbose increases median lifespan by approximately 20% in male mice and 5% in females. This longevity extension differs from dietary restriction based on a number of features, including the relatively small effects on weight and the sex-specifi...

Descripción completa

Detalles Bibliográficos
Autores principales: Smith, Byron J, Miller, Richard A, Ericsson, Aaron C, Harrison, David C, Strong, Randy, Schmidt, Thomas M
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6567620/
https://www.ncbi.nlm.nih.gov/pubmed/31195972
http://dx.doi.org/10.1186/s12866-019-1494-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6567620/
https://www.ncbi.nlm.nih.gov/pubmed/31195972
http://dx.doi.org/10.1186/s12866-019-1494-7

Ejemplares similares